Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125356921 | 12535692 | 1 | I | 20140405 | 20160622 | 20160707 | 20160707 | EXP | RU-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-119788 | RANBAXY | KARLOV VA, VLASOV PN, GLADOV BP, KAMELKOVA EG. CASES OF NON-STANDARD APPROACH TO TREATMENT OF SUPER-REFRACTORY STATUS EPILEPTICUS. ZH-NEVROPATOL-PSIKHIATR-IM-S-S-KORSAKOVA. 2015;115 (9):54-59 | 21.00 | YR | F | Y | 0.00000 | 20160707 | MD | RU | RU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125356921 | 12535692 | 1 | SS | CARBAMAZEPINE. | CARBAMAZEPINE | 1 | Unknown | 300 MG, DAILY (100 MG IN THE MORNING, 200 MG IN THE EVENING) | Y | U | 0 | 300 | MG | ||||||
| 125356921 | 12535692 | 2 | PS | TOPIRAMATE. | TOPIRAMATE | 1 | Unknown | 150 MG, DAILY | 76327 | 150 | MG | ||||||||
| 125356921 | 12535692 | 3 | SS | Convulex | VALPROIC ACID | 1 | Intravenous (not otherwise specified) | 1000 MG, DIRECT VENOUS INJECTION | U | U | 0 | ||||||||
| 125356921 | 12535692 | 4 | SS | Convulex | VALPROIC ACID | 1 | Intravenous (not otherwise specified) | MAXIMUM 3000 MG/DAY, SLOW INJECTION | U | U | 0 | ||||||||
| 125356921 | 12535692 | 5 | SS | Relanium | DIAZEPAM | 1 | Intravenous (not otherwise specified) | 40 MG, UNK | U | U | 0 | 40 | MG | ||||||
| 125356921 | 12535692 | 6 | SS | Sodium thiopental | THIOPENTAL SODIUM | 1 | Intravenous (not otherwise specified) | 1000 MG, SLOW INJECTION | U | U | 0 | 1000 | MG | ||||||
| 125356921 | 12535692 | 7 | SS | ARDUAN | PIPECURONIUM BROMIDE | 1 | Intravenous (not otherwise specified) | 4 MG, DIRECT VENOUS INJECTION | U | U | 0 | 4 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125356921 | 12535692 | 1 | Epilepsy |
| 125356921 | 12535692 | 2 | Epilepsy |
| 125356921 | 12535692 | 3 | Epilepsy |
| 125356921 | 12535692 | 5 | Epilepsy |
| 125356921 | 12535692 | 6 | Epilepsy |
| 125356921 | 12535692 | 7 | Epilepsy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125356921 | 12535692 | HO |
| 125356921 | 12535692 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125356921 | 12535692 | Drug ineffective | |
| 125356921 | 12535692 | Epilepsy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |